Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Shelagh M Szabo"'
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0180261 (2017)
Although brentuximab vedotin (BV) has changed the management of patients with relapsed or refractory Hodgkin lymphoma (RRHL), little information is available on routine clinical practice. We identified treatment patterns and costs of care among RRHL
Externí odkaz:
https://doaj.org/article/f87f7da477be4f12bc324191bf723fdc
Autor:
Ivana F. Audhya, Shelagh M. Szabo, Andrea Bever, Fiona O’Sullivan, Daniel C. Malone, David Feeny, Peter Neumann, Susan T. Iannaccone, P. Jayasinghe, Katherine L. Gooch
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-12 (2023)
Abstract Background The progression of Duchenne muscular dystrophy (DMD) is characterized by loss of ambulation, respiratory insufficiency, cardiomyopathy, and early mortality. DMD profoundly impacts health-related quality-of-life (HRQoL). However, f
Externí odkaz:
https://doaj.org/article/56e8e0813bd14337a96c803b7f7fba68
Autor:
Tina Li, Hannah Rochon, Shelagh M. Szabo, Emilia Kourmaeva, Megan Manuel, Vanessa Perez Patel
Publikováno v:
Reproductive, Female and Child Health, Vol 3, Iss 1, Pp n/a-n/a (2024)
Abstract Objective To identify and synthesize epidemiologic data for preterm labour (PTL) and preterm birth (PTB). Methods A systematic search, with protocol registered in PROSPERO, was implemented in MEDLINE and EMBASE and supplemented by web‐base
Externí odkaz:
https://doaj.org/article/43016f46dd9a41d8b923c38891fcb5ad
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background The North Star Ambulatory Assessment (NSAA) documents motor performance in ambulatory individuals with Duchenne muscular dystrophy (DMD). Health Utilities Index (HUI) scores, reflecting preferences for health-related quality-of-li
Externí odkaz:
https://doaj.org/article/d827b14871b44f358e99d3fe6e4f8dbc
Autor:
Shelagh M. Szabo, Ivana F. Audhya, David Feeny, Peter Neumann, Daniel C. Malone, Katherine L. Gooch
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-13 (2022)
Abstract Purpose Under a societal perspective, disease and treatment attributes that the general public deem important should be considered within value frameworks. The objective was to investigate how members of the general public value attributes b
Externí odkaz:
https://doaj.org/article/edf8f44d398a4072a7144e57cfb682ad
Autor:
Shelagh M. Szabo, Renna M. Salhany, Alison Deighton, Meagan Harwood, Jean Mah, Katherine L. Gooch
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-13 (2021)
Abstract Background Duchenne muscular dystrophy (DMD) is a severe rare progressive inherited neuromuscular disorder, leading to loss of ambulation (LOA) and premature mortality. The standard of care for patients with DMD has been treatment with corti
Externí odkaz:
https://doaj.org/article/1e8feea899d446fba63f3aa6eec15d46
Autor:
Ivana F. Audhya, Antoinette Cheung, Shelagh M. Szabo, Emma Flint, Conrad C. Weihl, Katherine L. Gooch
Publikováno v:
Journal of Neuromuscular Diseases. 9:477-492
Background The impact of age at autosomal recessive limb girdle muscular dystrophy (LGMDR) onset on progression to loss of ambulation (LOA) has not been well established, particularly by subtype. Objectives: To describe the characteristics of patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30ac79b364aff9ccd8eb0d2dd929d85e
https://doi.org/10.3233/jnd-210771
https://doi.org/10.3233/jnd-210771
Publikováno v:
Health Information & Libraries Journal.
Given the increasing volume of published research in bibliographic databases, efficient retrieval of evidence is crucial and represents an opportunity to integrate novel techniques such as text mining.To develop and validate a geographic search filte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088a8a9c66875e5726474c9c24b38764
https://doi.org/10.1111/hir.12471
https://doi.org/10.1111/hir.12471
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 15:307-316
BACKGROUND In lung cancer trials, overall survival is a well-validated and widely used endpoint; yet, in the context of adjuvant or curative intent treatments, disease-free survival (DFS) may be a better indicator of transformative patient outcomes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905dea17632e99377bda7e7d78ba396b
https://doi.org/10.1007/s40271-021-00552-w
https://doi.org/10.1007/s40271-021-00552-w
Autor:
Christina Qian, Shelagh M. Szabo, Katherine Gooch, Alexa Klimchak, Susan T. Iannaccone, Evan Popoff
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:1426-1437
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe X-linked progressive neurodegenerative disease characterized by loss of ambulation, cardiomyopathy, respiratory insufficiency, and early mo...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511227b777217bcfcafa764b40b90129
https://doi.org/10.18553/jmcp.2021.27.10.1426
https://doi.org/10.18553/jmcp.2021.27.10.1426